Authors: Nguyen, C Liang, GM Nguyen, TT Tsao-Wei, D Groshen, S Lubbert, M Zhou, JH Benedict, WF Jones, PA

Citation: C. Nguyen et al., Susceptibility of nonpromoter CpG islands to de novo methylation in normaland neoplastic cells, J NAT CANC, 93(19), 2001, pp. 1465-1472

Authors: Stoehlmacher, J Ghaderi, V Iqbal, S Groshen, S Tsao-Wei, D Park, D Lenz, HJ

Citation: J. Stoehlmacher et al., A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer, ANTICANC R, 21(4B), 2001, pp. 3075-3079

Authors: Lukas, J Gao, DQ Keshmeshian, M Wen, WH Tsao-Wei, D Rosenberg, S Press, MF

Citation: J. Lukas et al., Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer, CANCER RES, 61(7), 2001, pp. 3212-3219

Authors: Zhou, Q Sherwin, RP Parrish, C Richters, V Groshen, SG Tsao-Wei, D Markland, FS

Citation: Q. Zhou et al., Contortrostatin, a dimeric disintegrin from Agkistrodon contortrix contortrix, inhibits breast cancer progression, BREAST CANC, 61(3), 2000, pp. 249-260

Authors: Liu, D Naritoku, WY Tsao-Wei, D Groshen, S Neville, MA Taylor, CR Cote, RJ Imam, SA

Citation: D. Liu et al., LEA.135 expression: An independent and favorable prognostic biomarker for patients with primary invasive breast cancer, INT J CANC, 89(3), 2000, pp. 224-229

Authors: Datar, RH Naritoku, WY Li, PL Tsao-Wei, D Groshen, S Taylor, CR Imam, SA

Citation: Rh. Datar et al., Analysis of telomerase activity in ovarian cystadenomas, low-malignant-potential tumors, and invasive carcinomas, GYNECOL ONC, 74(3), 1999, pp. 338-345